期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS LetPub Score 5.4
50 ratings
Rate
Reputation 6.4 Influence 3.7 Speed 9.5 | ||||||||||||||||||||
期刊簡稱 | EUR J DRUG METAB PH | ||||||||||||||||||||
ISSN | 0378-7966 | ||||||||||||||||||||
E-ISSN | 2107-0180 | ||||||||||||||||||||
h-index | 34 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 5.30%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.springer.com/13318 | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ejdr | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Springer International Publishing | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 1976 | ||||||||||||||||||||
每年文章數 | 57每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 27.37% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-7966%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS] 的評論 | 撰寫評論 |
作者: 北海幼霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-16 19:19:23 評論於 This magazine does not have any article processing charges. Submissions are divided into OA (with an approximate APC of 20,000 RMB) and non-OA (we mainly choose non-OA, with a slightly higher chance of rejection, but no APC(0) 讚! | 北海幼霜 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:24:34 評論於 Thank you to the editors and reviewers; we are working hard to make revisions, but experiments take time; confirming the necessary time(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:39:30 評論於 1. Subject: Submission Section, Article Title, Pen Name. Content: The full content of the article. 2. Author information is included after the main text. Author information includes: your actual contact address, postal code, name, email address, landline phone number, mobile phone number, QQ number (indicate QQ name), and any other contact information you deem necessary to provide (such as a brief bio(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 21:18:53 評論於 What aspects should be paid attention to in the letters sent by journals?(0) 讚! | 陶宜三岁啦 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 10:37:26 評論於 How to write a letter asking for an extension?(0) 讚! | 上清雨真 |
作者: 北海幼霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-17 10:58:41 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Experience sharing: Submitted on 08.01, accepted on 11.16. Fast speed, high editing efficiency, and very professional reviewer comments. Our research content is "metabolic enzymes + pharmacokinetics + pharmacodynamics". Revisions were made twice, but no grammar issues were mentioned. Reviewers focused on the experimental standards, data processing, and logical reasoning of the paper itself. Phase one: 2021.08.01 New submission 2021.08.05 Under review Editor review 2021.08.09 Reviewers assigned Assigned reviewers 2021.08.17 Under review Review 2021.09.19 Major Revise Major revision (two reviewers, ten opinions) Phase two: 2021.10.08 Revision Submitted 2021.10.09 Editor Assigned Assigned editor 2021.10.10 Reviewers Assigned —— Under review Review by reviewers 2021.11.01 Major Revise Major revision (one reviewer, 1 opinion) Received: 2021.11.10 Revision Submitted 2021.11.14 Editor Decision - Accept 2021.11.16 Final Decision Accept(0) 讚! | 北海幼霜 |
作者: 五毒思柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-09 20:28:26 評論於 Is there a layout fee?(0) 讚! | 五毒思柔 |
作者: 东京语风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-21 10:35:38 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: I submitted an article on bioequivalence, and it took about three months from submission to acceptance. The first review came back with a lot of comments, but they were very fair. There were four reviewers for the first review and three for the second review, with fewer comments. After the second round of revisions, I was accepted in about 4 days(0) 讚! | 东京语风 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 19:46:43 評論於 It's a bit bleak, couldn't even keep that 1.5 points, how to go on?(0) 讚! | 凌霄高洁 |
作者: 猫巷少女杉月 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 08:17:09 評論於 Do we need to pay for the review fee? Is the page fee expensive? Thank you!(0) 讚! | 猫巷少女杉月 |
作者: 咏春承嗣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-08 22:26:40 評論於 Pharmacokinetics-related articles, received feedback for revision after one month. Although the submission was rejected, the feedback was comprehensive and helpful for learning(0) 讚! | 咏春承嗣 |
作者: sj_zrf@126.com 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2017-06-08 21:48:24 評論於 pharmacokinetic related article, 1 month gave a revised opinion, although rejectedThe revised comments were given in place, and the(0) 讚! | sj_zrf@126.com |
作者: 瑞新小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-07-04 22:46:20 評論於 Just received a preclinical pharmacokinetic article on animal medicine on June 30, 2016. The initial draft was submitted on May 13, 2016 and the review comments were received on June 17, 2016. Made minor revisions to 33 areas, some places where English was not fluent, some details that needed clarification, and some topics that needed discussion. Responded to the comments on June 22, and was accepted on June 30. Overall, it went smoothly, with not very high requirements for technical innovation (not necessarily using the most advanced technology for research), sufficient amount of data, and clear purpose, methods, and results. Being able to explain some issues and having some reference value is enough. I am researching a new drug(0) 讚! | 瑞新小仙女 |
作者: 暴风长志 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-03-26 20:19:46 評論於 Review Speed: 2.0 Experience sharing: Submitted a pharmacokinetics article. Received revisions within 2 months, with lots of detailed suggestions. They said my writing was not up to par. Then did a major revision, only to be rejected 4 days later. They said the writing didn't improve. The topic didn't fit their requirements. I wanted to say, why didn't you say it didn't fit earlier(0) 讚! | 暴风长志 |
作者: yedou_xuaner@163.com 領域: 医药科学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2015-03-26 13:53:31 評論於 2 months to first decision. Many detailed comments. You need to meticulously address the reviewer concerns. (0) 讚! | yedou_xuaner@163.com |
作者: 幽花连成 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-03-26 13:27:01 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Submitted an article on pharmacokinetics. Received feedback within 2 months, with a lot of detailed suggestions. They said my writing was not up to standard. Then I made major revisions, and 4 days later, received rejection... they said the writing had not improved. The theme did not meet their requirements, etc. I wanted to say, why didn't you say it didn't meet the requirements earlier?(0) 讚! | 幽花连成 |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-08-21 18:09:00 評論於 Journal Homepage URL: http://www.springer.com/biomed/p ... ience/journal/13318(0) 讚! | 匿名 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 18:26:06 評論於 Research focus: Metabolism(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 08:33:06 評論於 Biased Research Direction: Metabolism(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us